Hepatic Blood Clearance
Hepatic Blood Clearance - Related Videos
01:09
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
0 Views •
2025
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance. Most drugs undergo restrictive clearance, which is proportional to the...
01:14
Hepatic Drug Clearance: Role of Transporters
0 Views •
2025
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
01:09
Hepatic Drug Clearance: Effect of Protein Binding
0 Views •
2025
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound. For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
10:40
Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model
0 Views •
Cited by 10 •
2012
An optical system was developed to visualize hepatic microcirculation with FITC-labeled erythrocytes and to measure the partial pressure of oxygen in the microvessels with laser-assisted phosphorimetry. This method can be used to investigate physiological and pathological mechanisms by analyzing microvascular structure, diameter, blood flow velocity, and oxygen tension.
07:56
A Comprehensive Rat Model For Assessing Hepatic Transport Pathways Through Simultaneous Lymphatic And Blood Vascular Sampling
0 Views •
2026
This experimental protocol describes a hepatic lymph duct-cannulated rat model that enables direct and quantitative assessment of hepatic lymphatic and vascular drainage. The model allows simultaneous sampling of hepatic lymph and systemic blood to investigate hepatic transport, metabolism, and immune signaling, supporting studies of drug pharmacokinetics and liver-specific biology.
FAQs
The extraction ratio describes how effectively the liver removes a substance during its passage through hepatic sinusoids. Interpreting it alongside hepatic blood flow, protein binding, and intrinsic metabolic capacity helps distinguish whether clearance is more strongly influenced by delivery to the liver or by the liver’s ability to process the compound. This distinction supports pharmacokinetic predictions.
Membrane transporters help hepatocytes extract compounds from sinusoidal blood, after which phase I and phase II enzymes chemically modify them. These sequential processes can produce more water-soluble metabolites, allowing products to leave through bile or return to the circulation for renal elimination. Their coordinated activity determines how efficiently a compound is transformed and removed.
Hepatic blood flow controls how much circulating substance reaches the liver over time, while protein binding influences the compound’s distribution between circulating and extractable forms. Changes in either variable can alter the amount presented for hepatic processing and therefore change drug exposure. Considering both factors is important when predicting clearance in patients with altered circulation.
A substance undergoing substantial removal during its initial passage through the liver can experience a first-pass effect before the rest of its circulation is considered. The extent of this effect depends on hepatic extraction and the liver’s intrinsic metabolic capacity. Recognizing these relationships helps explain differences in systemic drug exposure and informs pharmacokinetic interpretation.
Clinical interpretation considers whether liver disease has changed intrinsic metabolic capacity, hepatic blood flow, or both. Reduced processing capacity or altered circulation can change drug exposure and the amount removed from blood. Clearance information therefore helps clinicians anticipate altered pharmacokinetics and evaluate whether dosing requirements may differ from those in patients with normal hepatic function.
After hepatocytes extract and chemically modify a compound, the resulting products may be released into bile or returned to the bloodstream for renal elimination. The pathway affects how the substance ultimately leaves the body and helps distinguish hepatic processing from final excretion. Tracking this disposition is useful when interpreting metabolite handling and overall drug clearance.